{"id":550317,"date":"2021-06-29T17:58:02","date_gmt":"2021-06-29T17:58:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=550317"},"modified":"2021-06-29T17:58:02","modified_gmt":"2021-06-29T17:58:02","slug":"hypertrophic-scar-market-epidemiology-and-market-forecast-analysis-research-report","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/hypertrophic-scar-market-epidemiology-and-market-forecast-analysis-research-report_550317.html","title":{"rendered":"Hypertrophic Scar Market, Epidemiology, and Market Forecast Analysis Research Report"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1585648587.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Hypertrophic Scar Market, Epidemiology, and Market Forecast Analysis Research Report\" src=\"https:\/\/www.abnewswire.com\/uploads\/1585648587.jpeg\" alt=\"Hypertrophic Scar Market, Epidemiology, and Market Forecast Analysis Research Report\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>DelveInsight Business Research LLP      <\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight\u2019s \u201cHypertrophic Scar Market Insights, Epidemiology, and Market Forecast-2030\u201d report delivers an in-depth understanding of the Hypertrophic Scar, historical and forecasted epidemiology as well as the Hypertrophic Scar market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.\n<\/div>\n<p style=\"text-align: justify;\"><strong>What are&nbsp;<\/strong><strong>Hypertrophic Scar?<\/strong><\/p>\n<p style=\"text-align: justify;\">Hypertrophic Scars are raised, red, rigid, inflexible cell-like, and cosmetic problems precipitated due to multiple underlying dermal injuries such as burn, surgery, and trauma during which aberrant wound healing with more pathological deposition of the extracellular matrix than degradation leads to their spawning.<\/p>\n<p style=\"text-align: justify;\"><strong>How Hypertrophic Scar affected population?<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Hypertrophic Scar Epidemiology &ndash;<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Females and males have equal risk of developing Hypertrophic Scar.<\/li>\n<li>Adolescents and pregnant women may have a greater probability of forming Hypertrophic Scar.<\/li>\n<li>Incidence rates of Hypertrophic Scar have been reported as high as 91% following extensive trauma, such as a deep burn injury, suggesting a role for the extent of trauma in their development.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Hypertrophic Scar Market Outlook<\/strong><\/p>\n<p style=\"text-align: justify;\">According to DelveInsight,&nbsp;<a rel=\"nofollow\" class=\"seoquake-nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/hypertrophic-scar-market\" ><strong>Hypertrophic Scar market<\/strong><\/a>&nbsp;in 7MM is expected to change in the study period 2017-2030. The key driver for the surge in Hypertrophic Scar market size is the rise in number of incident\/prevalent cases.&nbsp;<\/p>\n<p style=\"text-align: justify;\"><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/uploads\/e8b4ce2890e69090329d40064cbaf2a6.jpg\" alt=\"\" \/><\/p>\n<p style=\"text-align: justify;\"><strong>Neodyne Biosciences&rsquo; Embrace Advanced Scar Therapy System<\/strong>&nbsp;has been approved by the FDA top treat HTSs. It delivers mechano-modulation therapy to the injury site and surrounding tissues. The device includes a simple disposable applicator that transfers a predetermined level of strain to a single use adhesive silicone sheet, which is then adhered over the closed scar. This unique mechanism of action provides a uniform compressive strain, or stress-shield around a closed scar, which can minimize collagen proliferation and formation of scar tissue. The Embrace device was cleared by the FDA in September 2011 and is the only FDA-Cleared scar therapy system designed to relieve tension around incisions, general cuts and lacerations to prevent the formation of new, visible, raised scars before they start.<\/p>\n<p style=\"text-align: justify;\">The&nbsp;<a rel=\"nofollow\" class=\"seoquake-nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/hypertrophic-scar-market\" ><strong>Hypertrophic Scar market outlook<\/strong><\/a>&nbsp;of the report helps to build the detailed comprehension of the historic, current, and forecasted Hypertrophic Scar market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.<\/p>\n<p style=\"text-align: justify;\">To know more, request sample pages @<a rel=\"nofollow\" class=\"seoquake-nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/hypertrophic-scar-market\" ><strong>Hypertrophic Scar Market Landscape<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\"><strong>Which are the leading companies in Hypertrophic Scar market?<\/strong><\/p>\n<p style=\"text-align: justify;\">The pipeline of Hypertrophic scars is quiet weak with few potential key players, such as Henry Ford Health System\/ Gladerma, Phio Pharmaceuticals and others. The dynamics of HTS market is anticipated to change in the coming years owing to the improvement in the research and development activities so that market will comprise of efficient treatment options. The launch of emerging therapies is expected during the forecast period of 2020&ndash;2030.<\/p>\n<p style=\"text-align: justify;\">Request sample pages for more information on&nbsp;<a rel=\"nofollow\" class=\"seoquake-nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/hypertrophic-scar-market\" ><strong>Hypertrophic Scar Market Report<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\"><strong><span data-sheets-value=\"{\" data-sheets-userformat=\"{\">Table of contents<\/span><\/strong><\/p>\n<p style=\"text-align: justify;\"><span>1. Key Insights<\/span><\/p>\n<p style=\"text-align: justify;\"><span>2. Executive Summary of Hypertrophic Scar<\/span><\/p>\n<p style=\"text-align: justify;\"><span>3. Competitive Intelligence Analysis for Hypertrophic Scar<\/span><\/p>\n<p style=\"text-align: justify;\"><span>4. Hypertrophic Scar: Market Overview at a Glance<\/span><\/p>\n<p style=\"text-align: justify;\">4.1. Hypertrophic Scar Total Market Share (%) Distribution in 2017<\/p>\n<p style=\"text-align: justify;\">4.2. Hypertrophic Scar Total Market Share (%) Distribution in 2030<\/p>\n<p style=\"text-align: justify;\"><span>5. Hypertrophic Scar: Disease Background and Overview<\/span><\/p>\n<p style=\"text-align: justify;\">5.1. Introduction<\/p>\n<p style=\"text-align: justify;\">5.2. Sign and Symptoms&nbsp;<\/p>\n<p style=\"text-align: justify;\">5.3. Pathophysiology&nbsp;<\/p>\n<p style=\"text-align: justify;\">5.4. Risk Factors&nbsp;<\/p>\n<p style=\"text-align: justify;\">5.5. Diagnosis&nbsp;<\/p>\n<p style=\"text-align: justify;\"><span>6. Hypertrophic Scar Patient Journey<\/span><\/p>\n<p style=\"text-align: justify;\"><span>7. Hypertrophic Scar Epidemiology and Patient Population<\/span><\/p>\n<p style=\"text-align: justify;\">7.1. Epidemiology Key Findings<\/p>\n<p style=\"text-align: justify;\">7.2. Assumptions and Rationale: 7MM<\/p>\n<p style=\"text-align: justify;\">7.3. Epidemiology Scenario: 7MM<\/p>\n<p style=\"text-align: justify;\">7.3.1. Hypertrophic Scar Epidemiology Scenario in the 7MM (2017-2030)<\/p>\n<p style=\"text-align: justify;\">7.4. United States Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.4.1. Hypertrophic Scar Epidemiology Scenario in the United States (2017-2030)<\/p>\n<p style=\"text-align: justify;\">7.5. EU-5 Country-wise Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.1. Germany Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.1.1. Hypertrophic Scar Epidemiology Scenario in Germany (2017-2030)<\/p>\n<p style=\"text-align: justify;\">7.5.2. France Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.2.1. Hypertrophic Scar Epidemiology Scenario in France (2017-2030)<\/p>\n<p style=\"text-align: justify;\">7.5.3. Italy Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.3.1. Hypertrophic Scar Epidemiology Scenario in Italy (2017-2030)<\/p>\n<p style=\"text-align: justify;\">7.5.4. Spain Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.4.1. Hypertrophic Scar Epidemiology Scenario in Spain (2017-2030)<\/p>\n<p style=\"text-align: justify;\">7.5.5. United Kingdom Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.5.1. Hypertrophic Scar Epidemiology Scenario in the United Kingdom (2017-2030)<\/p>\n<p style=\"text-align: justify;\">7.5.6. Japan Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.6.1. Hypertrophic Scar Epidemiology Scenario in Japan (2017-2030)<\/p>\n<p style=\"text-align: justify;\"><span>8. Treatment Algorithm, Current Treatment, and Medical Practices<\/span><\/p>\n<p style=\"text-align: justify;\">8.1. Hypertrophic Scar Treatment and Management<\/p>\n<p style=\"text-align: justify;\">8.2. Hypertrophic Scar Treatment Algorithm&nbsp;<\/p>\n<p style=\"text-align: justify;\"><span>9. Unmet Needs<\/span><\/p>\n<p style=\"text-align: justify;\"><span>10. Key Endpoints of Hypertrophic Scar Treatment<\/span><\/p>\n<p style=\"text-align: justify;\"><span>11. Marketed Products<\/span><\/p>\n<p style=\"text-align: justify;\">11.1. List of Marketed Products in the 7MM<\/p>\n<p style=\"text-align: justify;\">11.2. Drug Name: Company Name<\/p>\n<p style=\"text-align: justify;\">11.2.1. Product Description<\/p>\n<p style=\"text-align: justify;\">11.2.2. Regulatory Milestones<\/p>\n<p style=\"text-align: justify;\">11.2.3. Other Developmental Activities<\/p>\n<p style=\"text-align: justify;\">11.2.4. Pivotal Clinical Trials<\/p>\n<p style=\"text-align: justify;\">11.2.5. Summary of Pivotal Clinical Trial<\/p>\n<p style=\"text-align: justify;\">List to be continued in report<\/p>\n<p style=\"text-align: justify;\"><span>12. Emerging Therapies<\/span><\/p>\n<p style=\"text-align: justify;\">12.1. Key Cross<\/p>\n<p style=\"text-align: justify;\">12.2. Drug Name: Company Name<\/p>\n<p style=\"text-align: justify;\">12.2.1. Product Description<\/p>\n<p style=\"text-align: justify;\">12.2.2. Other Developmental Activities<\/p>\n<p style=\"text-align: justify;\">12.2.3. Clinical Development<\/p>\n<p style=\"text-align: justify;\">12.2.4. Safety and Efficacy<\/p>\n<p style=\"text-align: justify;\">12.2.5. Product Profile<\/p>\n<p style=\"text-align: justify;\">List to be continued in report<\/p>\n<p style=\"text-align: justify;\"><span>13. Hypertrophic Scar: Seven Major Market Analysis<\/span><\/p>\n<p style=\"text-align: justify;\">13.1. Key Findings<\/p>\n<p style=\"text-align: justify;\">13.2. Hypertrophic Scar Market Size in 7MM<\/p>\n<p style=\"text-align: justify;\">13.3. Hypertrophic Scar Market Size by Therapies in the 7MM<\/p>\n<p style=\"text-align: justify;\"><span>14. Attribute analysis<\/span><\/p>\n<p style=\"text-align: justify;\"><span>15. 7MM: Market Outlook<\/span><\/p>\n<p style=\"text-align: justify;\">15.1. United States: Market Size<\/p>\n<p style=\"text-align: justify;\">15.1.1. Hypertrophic Scar Total Market Size in the United States<\/p>\n<p style=\"text-align: justify;\">15.1.2. Hypertrophic Scar Market Size by Therapies in the United States<\/p>\n<p style=\"text-align: justify;\">15.2. EU-5 countries: Market Size and Outlook<\/p>\n<p style=\"text-align: justify;\">15.3. Germany Market Size<\/p>\n<p style=\"text-align: justify;\">15.3.1. Hypertrophic Scar Total Market Size in Germany<\/p>\n<p style=\"text-align: justify;\">15.3.2. Hypertrophic Scar Market Size by Therapies in Germany<\/p>\n<p style=\"text-align: justify;\">15.4. France Market Size<\/p>\n<p style=\"text-align: justify;\">15.4.1. Hypertrophic Scar Total Market Size in France<\/p>\n<p style=\"text-align: justify;\">15.4.2. Hypertrophic Scar Market Size by Therapies in France<\/p>\n<p style=\"text-align: justify;\">15.5. Italy Market Size<\/p>\n<p style=\"text-align: justify;\">15.5.1. Hypertrophic Scar Total Market Size in Italy<\/p>\n<p style=\"text-align: justify;\">15.5.2. Hypertrophic Scar Market Size by Therapies in Italy<\/p>\n<p style=\"text-align: justify;\">15.6. Spain Market Size<\/p>\n<p style=\"text-align: justify;\">15.6.1. Hypertrophic Scar Total Market Size in Spain<\/p>\n<p style=\"text-align: justify;\">15.6.2. Hypertrophic Scar Market Size by Therapies in Spain<\/p>\n<p style=\"text-align: justify;\">15.7. United Kingdom Market Size<\/p>\n<p style=\"text-align: justify;\">15.7.1. Hypertrophic Scar Total Market Size in the United Kingdom<\/p>\n<p style=\"text-align: justify;\">15.7.2. Hypertrophic Scar Market Size by Therapies in the United Kingdom<\/p>\n<p style=\"text-align: justify;\">15.8. Japan Market Outlook<\/p>\n<p style=\"text-align: justify;\">15.8.1. Japan Market Size<\/p>\n<p style=\"text-align: justify;\">15.8.2. Hypertrophic Scar Total Market Size in Japan<\/p>\n<p style=\"text-align: justify;\">15.8.3. Hypertrophic Scar Market Size by Therapies in Japan<\/p>\n<p style=\"text-align: justify;\"><span>16. Access and Reimbursement Overview of Hypertrophic Scar<\/span><\/p>\n<p style=\"text-align: justify;\"><span>17. KOL Views<\/span><\/p>\n<p style=\"text-align: justify;\"><span>18. Market Drivers<\/span><\/p>\n<p style=\"text-align: justify;\"><span>19. Market Barriers<\/span><\/p>\n<p style=\"text-align: justify;\"><span>20. Appendix<\/span><\/p>\n<p style=\"text-align: justify;\">20.1. Bibliography<\/p>\n<p style=\"text-align: justify;\">20.2. Report Methodology<\/p>\n<p style=\"text-align: justify;\"><span>21. DelveInsight Capabilities<\/span><\/p>\n<p style=\"text-align: justify;\"><span>22. Disclaimer<\/span><\/p>\n<p style=\"text-align: justify;\"><span>23. About DelveInsight<\/span><\/p>\n<p style=\"text-align: justify;\"><span><em>*The table of contents is not exhaustive; the final content may vary.&nbsp;<\/em><\/span><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56407.html\" rel=\"nofollow\">DelveInsight<\/a><br \/><strong>Contact Person:<\/strong> Priya Maurya<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=hypertrophic-scar-market-epidemiology-and-market-forecast-analysis-research-report\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +919650213330<br \/><strong>City:<\/strong> Albany<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=hypertrophic-scar-market-epidemiology-and-market-forecast-analysis-research-report\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight Business Research LLP DelveInsight\u2019s \u201cHypertrophic Scar Market Insights, Epidemiology, and Market Forecast-2030\u201d report delivers an in-depth understanding of the Hypertrophic Scar, historical and forecasted epidemiology as well as the Hypertrophic Scar market trends in the United States, EU5 (Germany, &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/hypertrophic-scar-market-epidemiology-and-market-forecast-analysis-research-report_550317.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[406,423,420,403,404],"tags":[],"class_list":["post-550317","post","type-post","status-publish","format-standard","hentry","category-Pharmaceuticals-Biotech","category-Professional-Services","category-Science","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/550317","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=550317"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/550317\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=550317"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=550317"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=550317"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}